Table 2.
Characteristics | Participants |
---|---|
N = 28 | |
Mean age in years (SD) | 52.2 (13.5) |
Age Groups in years, n (%) | |
Age <40 | 6 (21.4) |
Age 40–59 | 12 (42.9) |
Age > 59 | 10 (35.7) |
Female, n (%) | 26 (92.9) |
Caucasian, n (%) | 26 (92.9) |
Average duration of symptoms in months | 119.4 |
Comorbid conditions (%) | |
Migraine | 21 (75) |
Vestibular disease | 10 (35.7) |
Depression | 6 (21.4) |
Anxiety | 11 (39.3) |
Number of patients currently or previously on Botox (%) | 10 (35.7) |